FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roger Connelly

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Prostate

Living Beings

Activities & Behaviors

Computer Simulation

Co-author Network

Publications

TOP 3
Gyorgy Petrovics; Wei Zhang; Mazen Makarem; Jesse P Street; Roger R Connelly; Leon Sun; Isabell A Sesterhenn; Vasantha Srikantan; Judd W Moul; Shiv Srivastava
Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients.
Chun-Ling Gao; Sudhir K Rawal; Leon Sun; Amina Ali; Roger R Connelly; Lionel L Bañez; Isabell A Sesterhenn; David G McLeod; Judd W Moul; Shiv Srivastava
Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.
Edmond L Paquette; Roger R Connelly; Leon Sun; Laurence R Paquette; Judd W Moul
Predictors of extracapsular extension and positive margins in African American and white men.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roger Connelly (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Gyorgy Petrovics; Wei Zhang; Mazen Makarem; Jesse P Street; Roger R Connelly; Leon Sun; Isabell A Sesterhenn; Vasantha Srikantan; Judd W Moul; Shiv Srivastava
Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients.
Oncogene 2004;23(2):605-11.
2003: Chun-Ling Gao; Sudhir K Rawal; Leon Sun; Amina Ali; Roger R Connelly; Lionel L Bañez; Isabell A Sesterhenn; David G McLeod; Judd W Moul; Shiv Srivastava
Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2545-50.
2003: Edmond L Paquette; Roger R Connelly; Leon Sun; Laurence R Paquette; Judd W Moul
Predictors of extracapsular extension and positive margins in African American and white men.
Urologic oncology 2003;21(1):33-8.
2003: Axel S Merseburger; Markus A Kuczyk; Jürgen Serth; Carsten Bokemeyer; Denise Y Young; Leon Sun; Roger R Connelly; David G McLeod; Fathollah K Mostofi; Shiv K Srivastava; Arnulf Stenzl; Judd W Moul; Isabell A Sesterhenn
Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues.
Oncology reports 2003;10(1):223-8.
2002: Edmond L Paquette; Leon Sun; Laurence R Paquette; Roger R Connelly; David G Mcleod; Judd W Moul
Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing.
Urology 2002;60(5):756-9.
2002: Zhiqiang Zou; Wei Zhang; Denise Young; Martin G Gleave; Paul Rennie; Theresa Connell; Roger R Connelly; Judd W Moul; Shiv Srivastava; Isabell A Sesterhenn
Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1172-7.
2002: Stacey G Koff; Roger R Connelly; JJ Bauer; David G McLeod; Judd W Moul
Primary hormonal therapy for prostate cancer: experience with 135 consecutive PSA-ERA patients from a tertiary care military medical center.
Prostate cancer and prostatic diseases 2002;5(2):152-8.
2002: M B Opell; J Zeng; JJ Bauer; Roger R Connelly; W Zhang; Isabell A Sesterhenn; Seong Mun; J W Moul; John H Lynch
Investigating the distribution of prostate cancer using three-dimensional computer simulation.
Prostate cancer and prostatic diseases 2002;5(3):204-8.
2001: Edmond L Paquette; Roger R Connelly; Isabell A Sesterhenn; W Zhang; Leon Sun; Laurence R Paquette; R Greenspan; David G Mcleod; Judd W Moul
Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era: implications for screening a high-risk group for prostate carcinoma.
Cancer 2001;92(10):2673-9.
2001: Axel S Merseburger; Roger R Connelly; Leon Sun; E Richter; Judd W Moul
Use of serum creatinine to predict pathologic stage and recurrence among radical prostatectomy patients.
Urology 2001;58(5):729-34.
2001: Judd W Moul; Roger R Connelly; Deborah P Lubeck; JJ Bauer; Leon Sun; SC Flanders; Gary D Grossfeld; Peter R Carroll
Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
The Journal of urology 2001;166(4):1322-7.
2001: J Zeng; J Bauer; W Zhang; Isabell A Sesterhenn; Roger R Connelly; J Lynch; J Moul; Seong Mun
Prostate biopsy protocols: 3D visualization-based evaluation and clinical correlation.
Computer aided surgery : official journal of the International Society for Computer Aided Surgery 2001;6(1):14-21.
2000: C V Smith; JJ Bauer; Roger R Connelly; T Seay; C Kane; John Foley; J Brantley Thrasher; Leo Kusuda; Judd W Moul
Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database.
The Journal of urology 2000;164(6):1964-7.
2000: J Zeng; JJ Bauer; X Yao; W Zhang; David G McLeod; Isabell A Sesterhenn; Roger R Connelly; J W Moul; Seong Mun
Investigating 3D tumor distribution for optimized diagnosis of prostate cancer.
Studies in health technology and informatics 2000;70():392-8.
2000: JJ Bauer; J Zeng; W Zhang; David G McLeod; Isabell A Sesterhenn; Roger R Connelly; Seong Mun; J W Moul
3-D computer visualization and interactive prostate biopsy simulation leads to an improved systematic technique for the detection of prostate cancer: clinical correlation.
Studies in health technology and informatics 2000;70():20-5.
2000: W Zhang; Isabell A Sesterhenn; Roger R Connelly; Fathollah K Mostofi; Judd W Moul
Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen.
The Journal of urology 2000;163(1):131-6.
1999: G B Stackhouse; Isabell A Sesterhenn; JJ Bauer; Fathollah K Mostofi; Roger R Connelly; S K Srivastava; Judd W Moul
p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy.
The Journal of urology 1999;162(6):2040-5.
1999: Judd W Moul; Roger R Connelly; RM Mooneyhan; W Zhang; Isabell A Sesterhenn; Fathollah K Mostofi; David G McLeod
Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients.
The Journal of urology 1999;162(2):394-7.
1999: Vasantha Srikantan; Isabell A Sesterhenn; L Davis; G R Hankins; F A Avallone; Jeffrey Livezey; Roger R Connelly; Fathollah K Mostofi; David G McLeod; Judd W Moul; Settara C Chandrasekharappa; Shiv Srivastava
Allelic loss on chromosome 6Q in primary prostate cancer.
International journal of cancer. Journal international du cancer 1999;84(3):331-5.
1999: JJ Bauer; J Zeng; J Weir; W Zhang; Isabell A Sesterhenn; Roger R Connelly; Seong Mun; Judd W Moul
Three-dimensional computer-simulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer.
Urology 1999;53(5):961-7.
1999: Chun-Ling Gao; S Maheshwari; RC Dean; L Tatum; RM Mooneyhan; Roger R Connelly; David G McLeod; Shiv Srivastava; Judd W Moul
Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer.
Urology 1999;53(4):714-21.
1999: Chun-Ling Gao; RC Dean; A Pinto; RM Mooneyhan; Roger R Connelly; David G McLeod; Shiv Srivastava; Judd W Moul
Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.
The Journal of urology 1999;161(4):1070-6.
1999: DM Preston; JJ Bauer; Roger R Connelly; T Sawyer; J Halligan; E S Leifer; David G McLeod; Judd W Moul
Prostate-specific antigen to predict outcome of external beam radiation for prostate cancer: Walter Reed Army Medical Center experience, 1988-1995.
Urology 1999;53(1):131-8.
1998: JJ Bauer; Roger R Connelly; I A Seterhenn; sudhir srivastava; David G McLeod; Judd W Moul
Statistical modeling using preoperative prognostic variables in predicting extracapsular extension and progression after radical prostatectomy for prostate cancer.
Military medicine 1998;163(9):615-9.
1998: MC Bettencourt; JJ Bauer; Isabell A Sesterhenn; Roger R Connelly; Judd W Moul
CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.
The Journal of urology 1998;160(2):459-65.
1998: JJ Bauer; Shiv Srivastava; Roger R Connelly; Isabell A Sesterhenn; DM Preston; David G McLeod; Judd W Moul
Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy.
Urology 1998;51(6):970-6.
1998: Judd W Moul; Roger R Connelly; B Perahia; David G McLeod
The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases.
The Journal of urology 1998;159(3):935-40.
1998: JJ Bauer; Roger R Connelly; I A Seterhenn; J Deausen; Shiv Srivastava; David G McLeod; Judd W Moul
Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer.
The Journal of urology 1998;159(3):929-33.
1997: T H Douglas; David G McLeod; Fathollah K Mostofi; RM Mooneyhan; Roger R Connelly; Judd W Moul; Isabell A Sesterhenn
Prostate-specific antigen-detected prostate cancer (stage T1c): an analysis of whole-mount prostatectomy specimens.
The Prostate 1997;32(1):59-64.
1997: JJ Bauer; Roger R Connelly; Isabell A Sesterhenn; MC Bettencourt; David G McLeod; sudhir srivastava; Judd W Moul
Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy.
Cancer 1997;79(5):952-62.